MicroRNAs as biomarkers of graft outcome

Transplantation Reviews

Volumn 28, Issue 3, 2014, Pages 111-118

  Amrouche, Lucile ^a,b,c   Rabant, Marion ^a,b,c   Anglicheau, Dany ^a,b,c,d  

^a INSTITUT NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d Labex Transplantex   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MOLECULAR MARKER; SMALL UNTRANSLATED RNA;

BIOGENESIS; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; BLOOD; CLINICAL PRACTICE; FIBROSING ALVEOLITIS; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RNA INTERFERENCE; ALLOGRAFT; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION;

ALLOGRAFTS; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; MICRORNAS; ORGAN TRANSPLANTATION;

EID: 84903743704     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2014.03.003     Document Type: Review

References (73)

1. Anglicheau D., Suthanthiran M. Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation 2008, 86:192-199.
2. Ameres S.L., Zamore P.D. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 2013, 14:475-488. [Epub 2013/06/27].
3. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610. [Epub 2010/07/28].
4. Chua J.H., Armugam A., Jeyaseelan K. MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 2009, 11:189-199. [Epub 2009/03/31].
5. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139. [Epub 2009/01/24].
6. Lee Y., Ahn C., Han J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419. [Epub 2003/09/26].
7. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355. [Epub 2004/09/17].
8. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
9. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640. [Epub 2005/11/08].
10. Brodersen P., Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 2009, 10:141-148. [Epub 2009/01/16].
11. Mah S.M., Buske C., Humphries R.K., Kuchenbauer F. miRNA*: a passenger stranded in RNA-induced silencing complex?. Crit Rev Eukaryot Gene Expr 2010, 20:141-148. [Epub 2010/12/08].
12. Pillai R.S., Bhattacharyya S.N., Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms?. Trends Cell Biol 2007, 17:118-126.
13. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006, 20:515-524. [Epub 2006/03/03].
14. Bronevetsky Y., Ansel K.M. Regulation of miRNA biogenesis and turnover in the immune system. Immunol Rev 2013, 253:304-316. [Epub 2013/04/05].
15. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854. [Epub 1993/12/03].
16. Kozomara A., Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res 2014, 42:D68-D73. [Epub 2013/11/28].
17. Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet 2012, 13:358-369. [Epub 2012/04/19].
18. Erson A.E., Petty E.M. MicroRNAs in development and disease. Clin Genet 2008, 74:296-306. [Epub 2008/08/21].
19. Lodish H.F., Zhou B., Liu G., Chen C.Z. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008, 8:120-130.
20. Grosshans H., Filipowicz W. Molecular biology: the expanding world of small RNAs. Nature 2008, 451:414-416.
21. Chang S., Wen S., Chen D., Jin P. Small regulatory RNAs in neurodevelopmental disorders. Hum Mol Genet 2009, 18:R18-R26. [Epub 2009/03/20].
22. Chen J.F., Callis T.E., Wang D.Z. microRNAs and muscle disorders. J Cell Sci 2009, 122:13-20. [Epub 2008/12/19].
23. da Costa Martins P.A., Leptidis S., Salic K., De Windt L.J. MicroRNA regulation in cardiovascular disease. Curr Drug Targets 2010, 11:900-906. [Epub 2010/04/27].
24. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342. [Epub 2011/01/21].
25. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233. [Epub 2009/01/27].
26. Peter M.E. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 2010, 29:2161-2164. [Epub 2010/03/02].
27. Bernstein E., Kim S.Y., Carmell M.A., et al. Dicer is essential for mouse development. Nat Genet 2003, 35:215-217.
28. Chandrasekaran K., Karolina D.S., Sepramaniam S., et al. Role of microRNAs in kidney homeostasis and disease. Kidney Int 2012, 81:617-627. [Epub 2012/01/13].
29. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874. [Epub 2011/11/19].
30. Waldman S.A., Terzic A. MicroRNA signatures as diagnostic and therapeutic targets. Clin Chem 2008, 54:943-944. [Epub 2008/05/30].
31. Group BDW Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
32. Chin L.J., Slack F.J. A truth serum for cancer-microRNAs have major potential as cancer biomarkers. Cell Res 2008, 18:983-984. [Epub 2008/10/04].
33. Hergenreider E., Heydt S., Treguer K., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012, 14:249-256. [Epub 2012/02/14].
34. Mitchell P.S., Parkin R.K., Kroh E.M., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518.
35. Gilad S., Meiri E., Yogev Y., et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3:e3148. [Epub 2008/09/06].
36. Etheridge A., Lee I., Hood L., Galas D., Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res 2011, 717:85-90. [Epub 2011/03/16].
37. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838. [Epub 2005/06/10].
38. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010, 285:17442-17452. [Epub 2010/04/01].
39. Keller S., Sanderson M.P., Stoeck A., Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006, 107:102-108. [Epub 2006/10/28].
40. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659. [Epub 2007/05/09].
41. Fichtlscherer S., De Rosa S., Fox H., et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107:677-684. [Epub 2010/07/03].
42. Taylor D.D., Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008, 110:13-21. [Epub 2008/07/01].
43. Arroyo J.D., Chevillet J.R., Kroh E.M., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011, 108:5003-5008. [Epub 2011/03/09].
44. Lorenzen J.M., Volkmann I., Fiedler J., et al. Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant 2011, 11:2221-2227. [Epub 2011/08/05].
45. Hanke M., Hoefig K., Merz H., et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 2010, 28:655-661. [Epub 2009/04/21].
46. Gonzales P.A., Pisitkun T., Hoffert J.D., et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009, 20:363-379. [Epub 2008/12/06].
47. Pisitkun T., Shen R.F., Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004, 101:13368-13373. [Epub 2004/08/25].
48. Zhou H., Cheruvanky A., Hu X., et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008, 74:613-621. [Epub 2008/05/30].
49. Xi Y., Nakajima G., Gavin E., et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007, 13:1668-1674. [Epub 2007/08/19].
50. Thomson J.M., Parker J., Perou C.M., Hammond S.M. A custom microarray platform for analysis of microRNA gene expression. Nat Methods 2004, 1:47-53. [Epub 2005/03/23].
51. Chen C., Ridzon D.A., Broomer A.J., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33:e179.
52. Kloosterman W.P., Wienholds E., de Bruijn E., Kauppinen S., Plasterk R.H. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods 2006, 3:27-29. [Epub 2005/12/22].
53. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201. [Epub 2009/12/08].
54. Camussi G., Deregibus M.C., Bruno S., Grange C., Fonsato V., Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 2011, 1:98-110. [Epub 2011/10/05].
55. Zernecke A., Bidzhekov K., Noels H., et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009, 2:ra81.
56. O'Connell R.M., Rao D.S., Chaudhuri A.A., Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010, 10:111-122.
57. Danger R., Pallier A., Giral M., et al. Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 2012, 23:597-606. [Epub 2012/01/28].
58. Sui W., Dai Y., Huang Y., Lan H., Yan Q., Huang H. Microarray analysis of MicroRNA expression in acute rejection after renal transplantation. Transpl Immunol 2008, 19:81-85.
59. Anglicheau D., Sharma V.K., Ding R., et al. MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci U S A 2009, 106:5330-5335.
60. Wilflingseder J., Regele H., Perco P., et al. miRNA profiling discriminates types of rejection and injury in human renal allografts. Transplantation 2013, 95:835-841. [Epub 2013/03/21].
61. Danger R., Paul C., Giral M., et al. Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS One 2013, 8:e60702.
62. Anglicheau D., Muthukumar T., Suthanthiran M. MicroRNAs: small RNAs with big effects. Transplantation 2010, 90:105-112. [Epub 2010/06/25].
63. Scian M.J., Maluf D.G., David K.G., et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 2011, 11:2110-2122. [Epub 2011/07/29].
64. Maluf D.G., Dumur C.I., Suh J.L., et al. The urine microRNA profile may help monitor post-transplant renal graft function. Kidney Int 2014, 85(2):439-449.
65. Ben-Dov I.Z., Muthukumar T., Morozov P., Mueller F.B., Tuschl T., Suthanthiran M. MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis. Transplantation 2012, 94:1086-1094. [Epub 2012/11/08].
66. Glowacki F., Savary G., Gnemmi V., et al. Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One 2013, 8:e58014.
67. Godwin J.G., Ge X., Stephan K., Jurisch A., Tullius S.G., Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A 2010, 107:14339-14344. [Epub 2010/07/24].
68. Verhoeven C.J., Farid W.R., de Ruiter P.E., et al. MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation. J Hepatol 2013, 59:1231-1238. [Epub 2013/08/10].
69. Farid W.R., Pan Q., van der Meer A.J., et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012, 18:290-297. [Epub 2011/09/21].
70. Gehrau R.C., Mas V.R., Villamil F.G., et al. MicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation. Am J Transplant 2013, 13:729-737. [Epub 2013/01/15].
71. Gelley F., Zadori G., Nemes B., et al. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis. J Gastroenterol Hepatol 2014, 29:121-127. [Epub 2013/09/17].
72. Asaoka T., Sotolongo B., Island E.R., et al. MicroRNA signature of intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies. Am J Transplant 2012, 12:458-468. [Epub 2011/10/27].
73. Wang E., Nie Y., Zhao Q., et al. Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation. J Cardiothorac Surg 2013, 8:165.